Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

ACUTE

primary: axillary hyperhidrosis

Back
1st line – 

topical aluminum chloride

Topical aluminum chloride is the first-line treatment for axillary hyperhidrosis.[2][11][19]

Commonly used preparations include 20% aluminum chloride in ethanol and 6.25% aluminum tetrachloride.

Local stinging and burning may occur due to formation of hydrochloric acid when sweat combines with the aluminum chloride. Topical baking soda or hydrocortisone cream may help if this occurs.[11]

Primary options

aluminum chloride topical: apply to the affected area(s) once daily at bedtime until desired effect is achieved, then taper to once weekly

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe and is approved for patients with primary axillary hyperhidrosis.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
2nd line – 

onabotulinumtoxinA

If symptoms do not resolve with aluminum chloride, onabotulinumtoxinA (botulinum toxin type A) injections may be considered.

Approved in the US for axillary use and can be effective for months at a time.[11][20]

The injection process may be painful. However, local topical anesthetic may help.[11]

Primary options

onabotulinumtoxinA: 50 units intradermally given in 0.1 to 0.2 mL aliquots to multiple sites (10-15) 1-2 cm apart in each axilla

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
3rd line – 

targeted alkali thermolysis (TAT) technology patch

If the patient does not respond to onabotulinumtoxinA or does not want repeated painful shots with temporary results, a targeted alkali thermolysis (TAT) technology patch is another treatment option. It has been approved by the Food and Drug Administration (FDA) for the treatment of primary axillary hyperhidrosis. In TAT, the sodium in the path interacting with the water of the sweat produces thermal energy causing local inactivation of the sweat glands for a period of several months. A double-blinded multicenter study showed a statistically significant improvement compared to placebo, with a decrease in sweat production by more than half in 60% of those treated.[21]

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
4th line – 

local microwave treatment

Local microwave treatment is another noninvasive treatment option for primary axillary hyperhidrosis.[16][22][23] It works by destroying eccrine sweat glands through thermolysis. In one study, 90% of patients who received microwave therapy experienced a 50% reduction in axillary sweat at 12 months follow-up.[24]

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
5th line – 

local sweat gland excision

If the patient does not respond to onabotulinumtoxinA or does not want repeated painful injections with temporary results, local sweat gland excision by curettage or liposuction should be considered next.

Local axillary gland surgeries (including subcutaneous gland resection with or without resection of the overlying skin, curettage-liposuction, or electrosurgical or laser glandular destruction) have been shown to be effective.[25][26][27][28][29] Local procedures seem to be more effective, with better patient satisfaction than thoracoscopic sympathetic surgeries, and have less compensatory and gustatory sweating.[30]

The procedure may be complicated by poor wound healing or scarring. Unlike surgical sympathectomy, local surgical procedures generally have no systemic manifestations (e.g., compensatory hyperhidrosis).

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
6th line – 

endoscopic thoracoscopic sympathectomy (ETS)

If symptoms persist, ETS may be considered.[31]​ The procedure is generally done on both sides at one sitting, under general anesthesia, and is a short-stay procedure in the majority of instances.

The specific hyperhidrosis disorder determines the level of the sympathetic procedure.

For example, surgery at the third (T3), fourth (T4), or fifth (T5) thoracic ganglia is for axillary hyperhidrosis.

Some controversy exists whether compensatory sweating is more problematic at higher sympathectomy levels, but patient selection is likely far more important.[32]

Sympathetic surgery at T3 or T4 can be expected to benefit 80% to 90% of patients with axillary hyperhidrosis. However, several studies have shown that sympathetic surgery in patients with axillary hyperhidrosis is less successful and that the level of patient satisfaction is lower than it is for patients with palmar hyperhidrosis.[14][33][34][35][36][37][38][40][Figure caption and citation for the preceding image starts]: Thoracoscopic view of the left upper posterior mediastinum with the sympathetic chain visualized over the 2nd, 3rd, and 4th costal heads (R2, R3, and R4, respectively)From the personal collection of Fritz Baumgartner, MD [Citation ends].com.bmj.content.model.Caption@43eb8e3b

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

primary: palmar hyperhidrosis

Back
1st line – 

topical aluminum chloride

Topical aluminum chloride is often the first-choice treatment for palmar hyperhidrosis but tends not to be as effective as it is for treating axillary hyperhidrosis.[2][11][19][31]​​[41]​​

Commonly used preparations include 20% aluminum chloride in ethanol and 6.25% aluminum tetrachloride.

Local stinging and burning may occur due to formation of hydrochloric acid when sweat combines with the aluminum chloride. Topical baking soda or hydrocortisone cream may help if this occurs.[11]

Primary options

aluminum chloride topical: apply to the affected area(s) once daily at bedtime until desired effect is achieved, then taper to once weekly

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
2nd line – 

iontophoresis

For patients who do not respond or cannot tolerate topical aluminum chloride on their hands, iontophoresis with tap water may be used.

Using an iontophoresis device, ions are introduced into cutaneous tissues via an electrical current.

The mechanism most likely involves the ionic current temporarily blocking the sweat duct at the level of the stratum corneum.

The addition of anticholinergics or onabotulinumtoxinA to the iontophoresis tap water may improve its efficacy.[11][42]

Skin irritation from galvanic currents may occur.

Iontophoresis is contraindicated in patients with pacemakers or metal implants, or who are pregnant.[11]

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
3rd line – 

endoscopic thoracoscopic sympathectomy (ETS)

ETS is appropriate for severe, debilitating palmar sweating when other treatments have failed.[31]

In these cases, the expected benefits generally outweigh the known side effects, which may include compensatory sweating.[9][14]

The specific hyperhidrosis disorder determines the level of the sympathetic procedure. For example, surgery at the second (T2) or third (T3) thoracic ganglia is recommended for palmar hyperhidrosis.

ETS is also appropriate for patients with severe palmar and severe plantar hyperhidrosis (palmoplantar hyperhidrosis) when other treatments have failed. It is emphasized that the ETS procedure is meant to cure the palmar hyperhidrosis, and any benefit for the feet is never the primary intent of the surgery.

Surgery can be performed at the T2 or T3 level, although some suggest the T4 level. The best level to select is unclear and controversial. Surgery at the T2 level may be more consistently curative with less dramatic failures than at T3,​[49][50]​ but is associated with an increased incidence of compensatory hyperhidrosis postoperatively.​​[48][49][50]​ However, excellent long-term results with a low (1.3%) rate of severe compensatory sweating have been reported by some using the T2 level.[52]

Successful outcomes for palmar sweating are achieved in >95% of cases.[51] Plantar sweating is improved in the short term in approximately 80% of cases, although not as dramatically as the palmar sweating.

Because of the higher incidence of moderate or severe compensatory hyperhidrosis, some recommend avoiding T2 procedures altogether, although others report excellent results using the T2 level.[49][52]​ Some even recommend levels of sympathetic intervention for palmoplantar hyperhidrosis at levels lower than T3 (i.e., over the 4th or 5th rib levels), although this may result in "moister hands".[48] It is suggested that proper patient selection is far more important than sympathectomy level in achieving patient satisfaction regarding compensatory sweating.[15] Some surgeons perform ramicotomy rather than sympathetic nerve/ganglion intervention to limit the severity of compensatory sweating. However, the incidence of recurrent sweating does seem to be higher with ramicotomy.[53] Thoracoscopic sympathetic intervention can be safe and effective in younger patients, even in early teenage years, and has been shown to result in markedly improved long-term quality of life compared to nonoperative cohorts.[54][Figure caption and citation for the preceding image starts]: Thoracoscopic view of the right upper posterior mediastinum with the sympathetic chain visualized over the 2nd and 3rd rib costal heads (R2 and R3, respectively). Transection of the sympathetic chain at the level of T2 on the right and left sides is curative for palmar hyperhidrosisFrom the personal collection of Fritz Baumgartner, MD [Citation ends].com.bmj.content.model.Caption@6ff7eaa4[Figure caption and citation for the preceding image starts]: Thoracoscopic view of the left upper posterior mediastinum with the sympathetic chain visualized over the 2nd, 3rd, and 4th costal heads (R2, R3, and R4, respectively)From the personal collection of Fritz Baumgartner, MD [Citation ends].com.bmj.content.model.Caption@7a9877c3

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

primary: plantar hyperhidrosis

Back
1st line – 

supportive care

Initial management should include keeping the feet as dry as possible by use of absorbent foot powders and shoe inserts, and frequent changing of socks and shoes.

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
2nd line – 

topical aluminum chloride with supportive care

Management of localized plantar sweating is primarily medical.

Topical aluminum chloride tends not to be as effective for plantar hyperhidrosis as it is for axillary hyperhidrosis.[41]

Commonly used preparations include 20% aluminum chloride in ethanol and 6.25% aluminum tetrachloride.

Local stinging and burning may occur due to formation of hydrochloric acid when sweat combines with the aluminum chloride. Topical baking soda or hydrocortisone cream may help if this occurs.[11]

Patients should keep their feet as dry as possible using absorbent foot powders and/or shoe inserts, with frequent changing of socks and shoes.

Primary options

aluminum chloride topical: apply to the affected area(s) once daily at bedtime until desired effect is achieved, then taper to once weekly

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
3rd line – 

iontophoresis with supportive care

For patients who do not respond or cannot tolerate topical aluminum chloride, iontophoresis with tap water may be used.

The mechanism most likely involves the ionic current temporarily blocking the sweat duct at the level of the stratum corneum.

Oral anticholinergics or onabotulinumtoxinA added to the iontophoresis tap water may improve its efficacy.[11][42]

Skin irritation from galvanic currents may occur.

Iontophoresis is contraindicated in patients with pacemakers or metal implants, or who are pregnant.[11]

Patients should keep their feet as dry as possible using absorbent foot powders and/or shoe inserts, with frequent changing of socks and shoes.

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

primary: craniofacial hyperhidrosis

Back
1st line – 

topical aluminum chloride

Topical aluminum chloride can be used for facial sweating.

Commonly used preparations include 20% aluminum chloride in ethanol and 6.25% aluminum tetrachloride.

Local stinging and burning may occur due to formation of hydrochloric acid when sweat combines with the aluminum chloride. Topical baking soda or hydrocortisone cream may help if this occurs.[11]

Primary options

aluminum chloride topical: apply to the affected area(s) once daily at bedtime until desired effect is achieved, then taper to once weekly

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

Back
2nd line – 

endoscopic thoracoscopic sympathectomy (ETS)

ETS is used for craniofacial sweating, although there is a higher incidence of patient dissatisfaction and complaints of compensatory sweating compared with palmar hyperhidrosis.[14][33][34][35][36][37]​​[38][39][40] Treatment of craniofacial hyperhidrosis surgically should be considered very carefully as the side effects can be severe.

However, most patients with craniofacial hyperhidrosis will have significant benefit from sympathetic surgery at the T2 level. [Figure caption and citation for the preceding image starts]: Thoracoscopic view of the right upper posterior mediastinum with the sympathetic chain visualized over the 2nd and 3rd rib costal heads (R2 and R3, respectively). Transection of the sympathetic chain at the level of T2 on the right and left sides is curative for palmar hyperhidrosisFrom the personal collection of Fritz Baumgartner, MD [Citation ends].com.bmj.content.model.Caption@19cc60a7

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

For those patients with symptoms exacerbated in known anxiety-provoking situations, a short-term oral anticholinergic taken as required can be considered together with any of the other therapies, although its side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

secondary hyperhidrosis

Back
1st line – 

treatment of underlying condition

This form of hyperhidrosis is a manifestation of an underlying pathology, and necessitates treating the primary cause of the disorder.

For example, focal sweating may result from acute spinal cord injury, cerebral or medullary infarcts, or other nerve injuries (e.g., posttraumatic vasomotor dystrophy), and facial gustatory sweating may be caused by Frey syndrome. More generalized sweating may be due to endocrine, neoplastic, infectious, drug, and toxicologic-related problems and, depending on the history and physical examination, may require additional testing.

Back
Consider – 

short-term anticholinergic

Treatment recommended for SOME patients in selected patient group

If symptoms persist after treatment of the underlying condition, oral anticholinergic medication to reduce sweating may be appropriate, although the side effects (e.g., dry eyes and mouth, urinary retention, cramps, weakness, nausea, and headache) may limit its usefulness.

Glycopyrrolate (as glycopyrronium) is also available as a topical wipe.

Primary options

glycopyrrolate: 1-2 mg orally twice or three times daily when required

OR

oxybutynin: 2.5 mg orally (immediate-release) once daily initially, increase gradually according to response, maximum 10 mg/day given in 2 divided doses; 5-10 mg orally (extended-release) once daily

OR

glycopyrronium topical: (2.4% pad) apply one pad to affected area once daily

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer